tacrolimus and Esophageal-Stenosis

tacrolimus has been researched along with Esophageal-Stenosis* in 2 studies

Other Studies

2 other study(ies) available for tacrolimus and Esophageal-Stenosis

Article	Year
Esophageal Stricture: Not Your Usual Culprit? Gastroenterology, 2022, Volume: 162, Issue:2 Topics: Amyloid Neuropathies, Familial; Esophageal Stenosis; Esophagitis; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Middle Aged; Mycophenolic Acid; Prednisone; Tacrolimus	2022
Esophageal squamous cell carcinoma after liver transplantation. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2005, Volume: 7, Issue:11 The occurrence of an oesophageal squamous cell carcinoma following liver transplantation is very infrequent. Such an event has been related to a history of alcohol-induced cirrhosis, as in other squamous cell tumours of the oropharynx. We report the case of a 64-year-old male patient diagnosed as having oesophageal squamous cell carcinoma six years after having had a liver transplant due to alcohol-induced cirrhosis. The tumour was treated surgically and consisted of an Ivor-Lewis oesophagectomy. The patient is disease-free 17 months after surgery. A review of the cases reported in the literature indicated treatment with chemotherapy and radiation therapy, and with excision in some cases. Generally, despite aggressive treatment the prognosis is poor. Topics: Alcoholism; Carcinoma, Squamous Cell; Cardia; Deglutition Disorders; Esophageal Neoplasms; Esophageal Stenosis; Esophagectomy; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Neoplasms, Multiple Primary; Postoperative Complications; Remission Induction; Stomach Neoplasms; Tacrolimus	2005

Article

Year

Esophageal Stricture: Not Your Usual Culprit?

Gastroenterology, 2022, Volume: 162, Issue:2

Topics: Amyloid Neuropathies, Familial; Esophageal Stenosis; Esophagitis; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Middle Aged; Mycophenolic Acid; Prednisone; Tacrolimus

2022

Esophageal squamous cell carcinoma after liver transplantation.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2005, Volume: 7, Issue:11

The occurrence of an oesophageal squamous cell carcinoma following liver transplantation is very infrequent. Such an event has been related to a history of alcohol-induced cirrhosis, as in other squamous cell tumours of the oropharynx. We report the case of a 64-year-old male patient diagnosed as having oesophageal squamous cell carcinoma six years after having had a liver transplant due to alcohol-induced cirrhosis. The tumour was treated surgically and consisted of an Ivor-Lewis oesophagectomy. The patient is disease-free 17 months after surgery. A review of the cases reported in the literature indicated treatment with chemotherapy and radiation therapy, and with excision in some cases. Generally, despite aggressive treatment the prognosis is poor.

Topics: Alcoholism; Carcinoma, Squamous Cell; Cardia; Deglutition Disorders; Esophageal Neoplasms; Esophageal Stenosis; Esophagectomy; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Neoplasms, Multiple Primary; Postoperative Complications; Remission Induction; Stomach Neoplasms; Tacrolimus

2005